Cagrilintide/semaglutide
A Research Study to Compare Blood Levels of Cagrilintide After Multiple Doses of Different Versions of Cagrilintide in Adults With Overweight or Obesity
Novo Nordisk · Phase 1 · Recruiting · Enrollment 234
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Cagrilintide B and Placebo Semaglutide I | Obesity or overweight | n/r | 17 | n/r | n/r |
| Cagrilintide D-Injection site 1 | Obesity or overweight | n/r | 17 | n/r | n/r |
| Cagrilintide D-Injection site 2 | Obesity or overweight | n/r | 17 | n/r | n/r |
| Cagrilintide D-Injection site 3 | Obesity or overweight | n/r | 17 | n/r | n/r |